Christina M. Wennerstrom

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.

Journal: American journal of hematology

Published: March 09, 2026

Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH).

Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH).

Journal: JHLT open

Published: March 27, 2025

Long-term real-world data of ustekinumab in ulcerative colitis: the Stockholm Ustekinumab Study (STOCUSTE).

Long-term real-world data of ustekinumab in ulcerative colitis: the Stockholm Ustekinumab Study (STOCUSTE).

Journal: European journal of gastroenterology & hepatology

Published: September 26, 2024

Frequency and outcomes of treatment dose escalation with biologics in moderate-to-severe psoriasis: a Swedish register study.

Frequency and outcomes of treatment dose escalation with biologics in moderate-to-severe psoriasis: a Swedish register study.

Journal: The Journal of dermatological treatment

Published: September 04, 2024

Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland.

Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland.

Journal: International journal of cardiology. Heart & vasculature

Published: July 04, 2024

Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Journal: Pulmonary circulation

Published: May 22, 2024

Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.

Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.

Journal: Therapeutic advances in gastroenterology

Published: August 19, 2023

Persistence of advanced systemic pharmacological treatment of moderate-to-severe psoriasis among bio-naïve patients-A retrospective register-based cohort study in Finland and Sweden.

Persistence of advanced systemic pharmacological treatment of moderate-to-severe psoriasis among bio-naïve patients-A retrospective register-based cohort study in Finland and Sweden.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 21, 2023

Drug utilization of biologic therapy in Crohn's disease and ulcerative colitis: a population-based Danish cohort study 2015-2020.

Drug utilization of biologic therapy in Crohn's disease and ulcerative colitis: a population-based Danish cohort study 2015-2020.

Journal: Scandinavian journal of gastroenterology

Published: February 21, 2023

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.

Journal: Scandinavian journal of gastroenterology

Published: April 06, 2021

Corrigendum to: Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden.

Corrigendum to: Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden.

Journal: Rheumatology advances in practice

Published: February 19, 2021

Societal impact for patients with psoriasis: A nationwide Swedish register study.

Societal impact for patients with psoriasis: A nationwide Swedish register study.

Journal: JAAD international

Published: February 13, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026